Colorectal Cancer Trial, Recruiting NCT07566559 Sponsor: Beijing Friendship Hospital Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT07566559
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been fully informed about the trial and have signed a written consent form
  • People who have been diagnosed with rectal adenocarcinoma (a specific type of rectal cancer) confirmed through a colonoscopy biopsy and pathology results
  • People whose cancer is classified as a locally advanced stage II or III rectal cancer, based on standard staging measurements, with no spread to distant parts of the body
  • People whose tumor is located within 10 cm of the anal opening, as measured by MRI scan
  • People who are planned to receive treatment before surgery (known as neoadjuvant therapy)
  • People who are 18 years of age or older, of any gender

Who may not be able to join:

  • People whose cancer has spread to distant organs in the body
  • People who have more than one primary colorectal cancer at the same time
  • People who have a history of a previous or other cancer, unless it was a fully cured case of cervical carcinoma in situ, basal cell skin cancer, or squamous cell skin cancer

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 63139203

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Beijing Friendship Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2025
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

To compare the complete response rates across different treatments.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov